EGFR and non-small cell lung carcinoma: The objective of our study was to compare the economic outcome of gene-guided gefitinib maintenance treatment with the routine follow-up following first-line platinum-based chemotherapy for advanced NSCLC with EGFR mutation from the perspective of the Chinese health care system.